Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - PharmaCyte Biotech, Inc. | pharmacyte_10k-043018.htm |
| EX-32.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3202.htm |
| EX-32.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3201.htm |
| EX-31.2 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3102.htm |
| EX-31.1 - CERTIFICATION - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex3101.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - PharmaCyte Biotech, Inc. | pharmacyte_10k-ex2101.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Annual Report on Form 10-K of PharmaCyte Biotech, Inc. for the year ended April 30, 2018 of our report dated July 20, 2018 included in its Registration Statements on Form S-3 (No. 333-220441) relating to the consolidated financial statements and consolidated financial statement schedules for the two years ended April 30, 2018 listed in the accompanying index.
| /s/ Armanino LLP | |
| Armanino LLP | |
| San Jose, California |
July 20, 2018